Patenting Dilemma for Startups: Number of Applied Patents, Patent Imitability, and Level of VC Funding

키워드

참고문헌 (76)

1. 최종열, "기술창업기업의 기술보유유형과 성과와의 관계", 벤처창업연구, 8(1), pp.29~36 (2013), 한국벤처창업학회[DOI]
2. 이영민, "A Study on the Positive Signals of New Technology-Based Ventures to Entice Venture Capitals in Korea : Exploring Human Capitals and Strategic Endorsements?", 벤처창업연구, 9(6), pp.23~35 (2014), 한국벤처창업학회[DOI]
3. Allison, J. R., "Valuable patents", The Georgetown Law Journal, 92, pp.435~ (2003)
4. Alvarez-Garrido, E., "Publications and patents in corporate venture-backed biotech", Nature Biotechnology, 31(6), pp.495~497 (2013)
5. Alvarez‐Garrido, E., "Are entrepreneurial venture's innovation rates sensitive to investor complementary assets? Comparing biotech ventures backed by corporate and independent VCs", Strategic Management Journal, 37(5), pp.819~834 (2016)
6. Autio, E., "Effects of age at entry, knowledge intensity, and imitability on international growth", Academy of Management Journal, 43(5), pp.909~924 (2000)
7. Barney, J., "Firm resources and sustained competitive advantage", Journal of Management, 17(1), pp.99~120 (1991)
8. Barrett, A., "Addicted to mergers", Business Week, 3658, pp.84~88 (1999)
9. Baum, J. A., "Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups", Journal of Business Venturing, 19(3), pp.411~436 (2004)
10. Beckman, C. M., "Early teams : The impact of team demography on VC financing and going public", Journal of Business Venturing, 22(2), pp.147~173 (2007)
11. Bell, C. G., "High-tech ventures: The guide for entrepreneurial success" (1991), Perseus Publishing
12. Blind, K., "Motives to patent : Empirical evidence from Germany", Research Policy, 35(5), pp.655~672 (2006)
13. Block, J. H., "Venture capital funding in the middle of the year 2011: are we back to pre‐crisis boom levels?", Strategic Change, 20(5‐6), pp.161~169 (2011)
14. Bowman, C., "Value creation versus value capture : towards a coherent definition of value in strategy", British Journal of Management, 11(1), pp.1~15 (2000)
15. Protecting their intellectual assets: Appropriability conditions and why US manufacturing firms patent(or not), "Cohen, W. M.", National Bureau of Economic Research, ~ (2000)
16. Conti, A., "Patents as signals for startup financing", The Journal of Industrial Economics, 61(3), pp.592~622 (2013)
17. Davila, A., "Venture capital financing and the growth of startup firms", Journal of Business Venturing, 18(6), pp.689~708 (2003)
18. De Carolis, D. M., "Competencies and imitability in the pharmaceutical industry : An analysis of their relationship with firm performance", Journal of Management, 29(1), pp.27~50 (2003)
19. Deeds, D. L., "The impact of firmspecific capabilities on the amount of capital raised in an initial public offering : Evidence from the biotechnology industry", Journal of Business Venturing, 12(1), pp.31~46 (1997)
20. De Rassenfosse, G., "How SMEs exploit their intellectual property assets : evidence from survey data", Small Business Economics, 39(2), pp.437~452 (2012)
21. Dierickx, I., "Asset stock accumulation and sustainability of competitive advantage", Management Science, 35(12), pp.1504~1511 (1989)
22. Dollinger, M. J., "The effect of reputation on the decision to joint venture", Strategic Management Journal, pp.127~140 (1997)
23. Dushnitsky, G., "When do incumbents learn from entrepreneurial ventures? : Corporate venture capital and investing firm innovation rates", Research Policy, 34(5), pp.615~639 (2005)
24. Ernst, H., "Patent applications and subsequent changes of performance : evidence from time-series cross-section analyses on the firm level", Research Policy, 30(1), pp.143~157 (2001)
25. Ernst, H., "Patent information for strategic technology management", World Patent Information, 25(3), pp.233~242 (2003)
26. Gambardella, A., "Science and innovation: The US pharmaceutical industry during the 1980s" (1995), Cambridge University Press
27. Gans, J. S., "The product market and the market for"ideas" : commercialization strategies for technology entrepreneurs", Research Policy, 32(2), pp.333~350 (2003)
28. Gilsing, V., "Exploration and exploitation in innovation systems : The case of pharmaceutical biotechnology", Research Policy, 35(1), pp.1~23 (2006)
29. Gompers, P. A., "Optimal investment, monitoring, and the staging of venture capital", The Journal of Finance, 50(5), pp.1461~1489 (1995)
30. Gompers, P., "The venture capital revolution", The Journal of Economic Perspectives, 15(2), pp.145~168 (2001)
31. Grant, R. M., "The resource-based theory of competitive advantage : implications for strategy formulation", California Management Review, 33(3), pp.114~135 (1991)
32. Greene, W. H., "Econometric Analysis" (1997), Prentice-Hall
33. Guellec, D., "Applications, grants and the value of patent", Economics Letters, 69(1), pp.109~114 (2000)
34. Hall, B. H., "Is there a role for patents in the financing of new innovative firms?", Industrial and Corporate Change, 28(3), pp.657~680 (2019)
35. Hall, B. H., "Recent research on the economics of patents", Annual Review of Economics, 4(1), pp.541~565 (2012)
36. Hall, B. H., "Market value and patent citations", RAND Journal of Economics, pp.16~38 (2005)
37. Hall, B. H., "The patent paradox revisited: an empirical study of patenting in the US semiconductor industry, 1979-1995", RAND Journal of Economics, pp.101~128 (2001)
38. To Be Financed or Not…: The Role of Patents for Venture Capital-Financing, "Häussler, C.", ZEW-Centre for European Economic Research, ~ (2012)
39. Heckman, J. J., "Sample selection bias as a specification error", Econometrica, 47, pp.153~161 (1979)
40. Hellmann, T., "Venture capitalists : the coaches of Silicon Valley", The Silicon Valley Edge, 113(6), pp.276~294 (2000)
41. Henderson, R., "Scale, scope, and spillovers: the determinants of research productivity in drug discovery", The Rand Journal of Economics, pp.32~59 (1996)
42. Hoenen, S., "The diminishing signaling value of patents between early rounds of venture capital financing", Research Policy, 43(6), pp.956~989 (2014)
43. Holgersson, M., "Patent management in entrepreneurial SMEs : a literature review and an empirical study of innovation appropriation, patent propensity, and motives", R&D Management, 43(1), pp.21~36 (2013)
44. "Gilead Sciences to acquire privately held cellular therapy company Cell Design Labs for US$567mln" (2017)[URL]
45. Hsu, D. H., "Experienced entrepreneurial founders, organizational capital, and venture capital funding", Research Policy, 36(5), pp.722~741 (2007)
46. Hsu, D. H., "Patents as quality signals for entrepreneurial ventures", Academy of Management Proceedings, 2008(1), pp.1~6 (2008)
47. Jaffe, A. B., "Geographic localization of knowledge spillovers as evidenced by patent citations", The Quarterly Journal of Economics, 108(3), pp.577~598 (1993)
48. Katila, R., "Swimming with sharks: Technology ventures, defense mechanisms and corporate relationships", Administrative Science Quarterly, 53(2), pp.295~332 (2008)
49. Kitching, J., "Intellectual property management in the small and medium enterprise(SME)", Journal of Small Business and Enterprise Development, 5(4), pp.327~335 (1998)
50. Kortum, S., "Entrepreneurial inputs and outcomes: New studies of entrepreneurship in the United States", pp.1~44 (2001), Emerald Group Publishing Limited
51. Lazonick, W., "US biopharmaceutical finance and the sustainability of the biotech business model", Research Policy, 40(9), pp.1170~1187 (2011)
52. Lepak, D. P., "Value creation and value capture : a multilevel perspective", Academy of Management Review, 32(1), pp.180~194 (2007)
53. Levin, R. C., "Appropriating the returns from industrial research and development", Brookings Papers on Economic Activity, 1987(3), pp.783~831 (1987)
54. Mangematin, V., "Development of SMEs and heterogeneity of trajectories : the case of biotechnology in France", Research Policy, 32(4), pp.621~638 (2003)
55. Mann, R. J., "Patents, venture capital, and software start-ups", Research Policy, 36(2), pp.193~208 (2007)
56. Mansfield, E., "Patents and innovation : an empirical study", Management Science, 32(2), pp.173~181 (1986)
57. Markman, G. D., "Patents as surrogates for inimitable and non-substitutable resources", Journal of Management, 30(4), pp.529~544 (2004)
58. Mogee, M. E., "Using patent data for technology analysis and planning", Research-Technology Management, 34(4), pp.43~49 (1991)
59. Mowery, D. C., "Strategic alliances and interfirm knowledge transfer", Strategic Management Journal, 17(S2), pp.77~91 (1996)
60. Powell, W. W., "The spatial clustering of science and capital : Accounting for biotech firm-venture capital relationships", Regional Studies, 36(3), pp.291~305 (2002)
61. Powell, W. W., "Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology", Administrative Science Quarterly, pp.116~145 (1996)
62. Priem, R. L., "Is the resource-based"view"a useful perspective for strategic management research?", Academy of Management Review, 26(1), pp.22~40 (2001)
63. Rao, H., "The social construction of reputation: Certification contests, legitimation, and the survival of organizations in the American automobile industry: 1895–1912", Strategic Management Journal, 15(S1), pp.29~44 (1994)
64. Rothaermel, F. T., "Old technology meets new technology : Complementarities, similarities, and alliance formation", Strategic Management Journal, 29(1), pp.47~77 (2008)
65. Sapienza, H. J., "When do venture capitalists add value?", Journal of Business Venturing, 7(1), pp.9~27 (1992)
66. Sattler, H., "Appropriability of product innovations: An empirical analysis for Germany", International Journal of Technology Management, 26(5-6), pp.502~516 (2003)
67. Shapiro, C., "Navigating the patent thicket : Cross licenses, patent pools, and standard setting", Innovation Policy and the Economy, 1, pp.119~150 (2000)
68. Simonin, B. L., "Ambiguity and the process of knowledge transfer in strategic alliances", Strategic Management Journal, pp.595~623 (1999)
69. Stinchcombe, A. L., "Social structure and organizations", Handbook of Organizations, 7, pp.142~193 (1965)
70. Stuart, T., "Interorganizational Endorsements and the Performance of Entrepreneurial Ventures", Administrative Science Quarterly, 44(2), pp.315~349 (1999)
71. Teece, D. J., "Profiting from technological innovation : Implications for integration, collaboration, licensing and public policy", Research Policy, 15(6), pp.285~305 (1986)
72. Thumm, N., "Strategic patenting in biotechnology", Technology Analysis & Strategic Management, 16(4), pp.529~538 (2004)
73. Trajtenberg, M., "A penny for your quotes: patent citations and the value of innovations", The Rand Journal of Economics, pp.172~187 (1990)
74. Van Zeebroeck, N., "Claiming more : the increased voluminosity of patent applications and its determinants", Research Policy, 38(6), pp.1006~1020 (2009)
75. Williamson, O. E., "The economic institutions of capitalism" (1985), Simon and Schuster
76. Zahra, S. A., "Technology strategy and new venture performance : a study of corporate-sponsored and independent biotechnology ventures", Journal of Business Venturing, 11(4), pp.289~321 (1996)

관련 논문AI추천